Page 347 - Read Online

Paul J Cancer Metastasis Treat 2020;6:29 I http://dx.doi.org/10.20517/2394-4722.2020.63 Page 25 of 31

Conflicts of interest
The author declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
A written informed consent for publication was provided.

Copyright
© The Author(s) 2020.

REFERENCES
1. Noble D. A theory of biological relativity: no privileged level of causation. Interface Focus 2012;2:55-64.
2. Noble D. A biological relativity view of the relationships between genomes and phenotypes. Prog Biophys Mol Biol 2013;111:59-65.
3. Noble D. The music of life. Oxford; 2006.
4. Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 2010;18:884-901.
5. McAllister SS, Weinberg RA. Tumor-host interactions: a far-reaching relationship. J Clin Oncol 2010;28:4022-8.
6. Al-Zoughbi W, Huang J, Paramasivan GS, Till H, Pichler M, et al. Tumor macroenvironment and metabolism. Semin Oncol 2014;41:281-95.
7. McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat
Cell Biol 2014;16:717-27.
8. Borniger JC. Central regulation of breast cancer growth and metastasis. J Cancer Metastasis Treat 2019;5.
9. Borniger JC, Walker Ii WH, Surbhi Emmer KM, Zhang N, Zalenski AA, et al. A role for hypocretin/orexin in metabolic and sleep
abnormalities in a mouse model of non-metastatic breast cancer. Cell Metab 2018;28:118-29.e5.
10. Paul D. Cancer the big picture: seeing the forest beyond the trees. Oncolog-Hematolog 2015;1:28-30.
11. Udriște O. Gena ancestrală și originea cancerului (in Romanian). Bucharest, Romania: Editura științifică și enciclopedică;1978.
12. Arechaga J. On the boundary between development and neoplasia. An interview with Professor G. Barry Pierce. Int J Dev Biol 1993;37:5-16.
13. Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev
Mol Cell Biol 2019;20:69-84.
14. Gallik KL, Treffy RW, Nacke LM, Ahsan K, Rocha M, et al. Neural crest and cancer: divergent travelers on similar paths. Mech Dev
2017;148:89-99.
15. Vincent MD. The animal within: carcinogenesis and the clonal evolution of cancer cells are speciation events sensu stricto. Evolution
2010;64:1173-83.
16. Vincent MD. Cancer: beyond speciation. Adv Cancer Res 2011;112:283-350.
17. Vincent M. Cancer: a de-repression of a default survival program common to all cells? a life-history perspective on the nature of cancer.
Bioessays 2012;34:72-82.
18. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
19. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
20. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007;8:341-52.
21. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med 2008;359:2814-23.
22. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, et al. Cancer genome landscapes. Science 2013;339:1546-58.
23. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
24. Sugarbaker EV. Cancer metastasis: a product of tumor-host interactions. Curr Probl Cancer 1979;3:1-59.
25. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-5.
26. Price JE, Naito S, Fidler IJ. Growth in an organ microenvironment as a selective process in metastasis. Clin Exp Metastasis 1988;96:91-
102.
27. McDonald OG, Li X, Saunders T, Tryggvadottir R, Mentch SJ, et al. Epigenomic reprogramming during pancreatic cancer progression
links anabolic glucose metabolism to distant metastasis. Nat Genet 2017;49:367-76.
28. Aytes A, Giacobbe A, Mitrofanova A, Ruggero K, Cyrta J, et al. NSD2 is a conserved driver of metastatic prostate cancer progression.
Nat Commun 2018;9:5201.
29. Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell 2017;168:670-91.
30. Hendrix MJC, Seftor EA, Seftor REB, Kasemeier-Kulesa J, Kulesa PM, et al. Reprogramming metastatic tumour cells with embryonic
microenvironments. Nat Rev Cancer 2007;7:246-55.
31. Telerman A, Amson R. The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat Rev Cancer
2009;9:206-16.
32. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54.
33. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006;5:1597-601.